TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
CC

Chemours Co

Basic Materials · Specialty Chemicals

14.20$ -3.7% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CC
Line item 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – +5.7% +6.4% +5.4% -3.8% +20.3% +0.9% -1.4% -2.4% +6.6% +1.2% +8.0% -8.9% -1.8%
– – +8.0% -0.9% +17.3% +11.0% +36.8% -5.7% -15.7% -5.2% +27.0% -3.9% +19.3% -21.1% -0.8%
– – – – +0.0% +146.4% +72.5% -22.8% -21.5% +17.2% +31.3% -24.1% +9.2% -40.7% -5.8%
– – – – – +146.4% +72.5% -22.8% -21.5% +17.2% +31.3% -24.1% +9.2% -40.7% -5.8%
– – +4.6% +1.0% +9.6% -6.1% +13.9% -6.3% -21.7% -24.2% +40.9% -13.1% -2.6% +26.2% -11.8%
– – +8.0% -0.3% -7.6% -21.1% +21.9% +22.7% -5.9% -13.0% +17.0% +27.8% -3.7% +8.9% +6.6%
– – +6.4% +11.3% -4.0% -12.4% +8.0% +9.4% +17.1% -9.8% -2.7% -6.2% +9.6% -1.0% -2.7%
– – +0.0% +0.0% -16.2% -7.8% +0.0% +0.0% +0.0% +0.0% -33.3% +0.0% +0.0% -54.9% +0.0%
– – -41.4% -35.3% -9.1% +70.0% -23.5% +115.4% -25.0% -33.3% -57.1% +116.7% -76.9% +0.0% -33.3%
– – +12.2% -1.6% +167.6% -3.4% +7.9% -1.3% +3.5% -4.5% +3.2% +1.0% +15.0% -8.0% +3.2%
– – +19.3% -4.4% +4.2% +20.8% -6.9% +3.7% -9.8% -6.4% +28.8% +1.8% +31.5% -27.5% -6.5%
– – +33.3% -21.4% -85.1% -128.2% – – – -61.0% +7.7% +9.5% +15.2% +0.9% -2.8%
– – +15.7% -2.1% -5.9% -6.5% +21.6% +5.8% -20.8% -9.0% +39.1% +6.0% -6.3% -1.2% -17.1%
– – +0.0% +0.0% +391,400.0% -9.9% +16.1% -3.4% +0.3% +0.8% -7.0% -3.6% +11.1% +1.7% +1.1%
– – +1.5% +12.0% -96.6% -20.6% +760.0% +17.9% -32.1% +18.0% +33.0% +2.4% -33.4% -18.0% -58.6%
– – – – – – – +153.2% -14.8% +4.3% +34.0% +24.3% -17.9% -3.6% -29.0%
– +0.0% +0.0% +0.0% -1.0% +1.3% +4.1% -4.4% -9.7% +0.9% +1.4% -6.2% -5.9% +0.7% +0.4%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?